Abbott India Ltd vs Pfizer Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 22, 2026

Key Highlights

The Latest Trading Price of Abbott India Ltd is ₹ 26220 as of 19 Jun 15:30 . The P/E Ratio of Abbott India Ltd changed from 46.1 on March 2021 to 46.2 on March 2025 . This represents a CAGR of 0.04% over 5 yearsThe P/E Ratio of Pfizer Ltd changed from 41.6 on March 2021 to 23.9 on March 2025 . This represents a CAGR of -10.49% over 5 years The Market Cap of Abbott India Ltd changed from ₹ 31850 crore on March 2021 to ₹ 65302 crore on March 2025 . This represents a CAGR of 15.44% over 5 yearsThe Market Cap of Pfizer Ltd changed from ₹ 20684 crore on March 2021 to ₹ 18317 crore on March 2025 . This represents a CAGR of -2.40% over 5 years The revenue of Abbott India Ltd for the Mar '26 is ₹ 1785 crore as compare to the Dec '25 revenue of ₹ 1793 crore. This represent the decline of -0.49% The revenue of Pfizer Ltd for the Mar '26 is ₹ 678.99 crore as compare to the Dec '25 revenue of ₹ 683.24 crore. This represent the decline of -0.62% The ebitda of Abbott India Ltd for the Mar '26 is ₹ 556.44 crore as compare to the Dec '25 ebitda of ₹ 533.23 crore. This represent the growth of 4.35% The ebitda of Pfizer Ltd for the Mar '26 is ₹ 285.71 crore as compare to the Dec '25 ebitda of ₹ 208.2 crore. This represent the growth of 37.23% The net profit of Abbott India Ltd changed from ₹ 328.01 crore to ₹ 394.93 crore over 8 quarters. This represents a CAGR of 9.73% The net profit of Pfizer Ltd changed from ₹ 150.71 crore to ₹ 199.82 crore over 8 quarters. This represents a CAGR of 15.15% The Dividend Payout of Abbott India Ltd changed from 84.61 % on March 2021 to 71.36 % on March 2025 . This represents a CAGR of -3.35% over 5 yearsThe Dividend Payout of Pfizer Ltd changed from 32.18 % on March 2021 to 98.34 % on March 2025 . This represents a CAGR of 25.03% over 5 years .

About Abbott India Ltd

Abbott India Ltd Share Price Overview Abbott India Ltd share price history records the movement of the stock in various phases of the market.
Company developments, as well as the general trends in the pharmaceutical industry, have influenced this movement.
As a healthcare-oriented company, the stock tends to respond to fluctuations in the demand of drugs, regulatory activities, and the general mood of investors.
The past performance of the stock gives the investors an idea of how it has reacted to the change in earnings, product portfolio development, and significant company occurrences at various times. Long-Term Performance The stock price performance of Abbott India Ltd has seen phases of fluctuation over time, with a 18% CAGR over the last 10 years.
This reflects movement across different market conditions, with periods of strength and correction.

About Pfizer Ltd

Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
It has its own manufacturing facility at Goa and Thane.
It has the distinction of being the first pharmaceutical company in India to start clinical research.
The Company sells products in nearly 185 countries having 43 manufacturing sites globally.

FAQs for the comparison of Abbott India Ltd and Pfizer Ltd

Which company has a larger market capitalization, Abbott India Ltd or Pfizer Ltd?

Market cap of Abbott India Ltd is 55,719 Cr while Market cap of Pfizer Ltd is 20,725 Cr

What are the key factors driving the stock performance of Abbott India Ltd and Pfizer Ltd?

The stock performance of Abbott India Ltd and Pfizer Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Abbott India Ltd and Pfizer Ltd?

As of June 22, 2026, the Abbott India Ltd stock price is INR ₹26220.8. On the other hand, Pfizer Ltd stock price is INR ₹4530.4.

How do dividend payouts of Abbott India Ltd and Pfizer Ltd compare?

To compare the dividend payouts of Abbott India Ltd and Pfizer Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.